Article citationsMore>>

US Food and Drug Administration (2015) Drug Safety Communication: FDA Warns That SGLT2 Inhibitors for Diabetes May Result a Serious Condition of Too Much Acid in Blood. 15 May 2015.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.